CAH vs IBTA · P/E 35, rev $254.25B vs rev $342.4M
Cardinal Health Inc (CAH) versus Ibotta, Inc. (IBTA) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Ibotta, Inc. (IBTA) is a software - application company listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported IBTA revenue for 2025-12-31 was $342.4M. Net income was $3.6M. Revenue was down 6.8% from 2024-12-31 to 2025-12-31. IBTA currently screens at market cap $764.6M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. IBTA currently screens at market cap $764.6M.
Not investment advice. Open the CAH and IBTA stock pages for the full models.
Not investment advice.